Search hospitals
>
Arizona
>
Phoenix
Barrow Neurological Institute
Claim this profile
Phoenix, Arizona 85013
Global Leader in Amyotrophic Lateral Sclerosis
Global Leader in Alzheimer's Disease
Conducts research for Parkinson's Disease
Conducts research for Epilepsy
Conducts research for Brain Tumor
160 reported clinical trials
16 medical researchers
Summary
Barrow Neurological Institute is a medical facility located in Phoenix, Arizona. This center is recognized for care of Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Parkinson's Disease, Epilepsy, Brain Tumor and other specialties. Barrow Neurological Institute is involved with conducting 160 clinical trials across 199 conditions. There are 16 research doctors associated with this hospital, such as Shafeeq S. Ladha, Anna Burke, Holly Shill, MD, and Margeaux E Snell, MD.
Area of expertise
Amyotrophic Lateral Sclerosis
Barrow Neurological Institute has run 29 trials for Amyotrophic Lateral Sclerosis. Some of their research focus areas include:
Alzheimer's Disease
Barrow Neurological Institute has run 24 trials for Alzheimer's Disease. Some of their research focus areas include:
Top PIs
Shafeeq S. Ladha
Barrow Neurological Institute
1 year of reported clinical research
Anna Burke
Barrow Neurological Institute
6 years of reported clinical research
Holly Shill, MD
Barrow Neurological Institute
5 years of reported clinical research
Margeaux E Snell, MD
St. Joseph's Hospital and Medical Center
5 years of reported clinical research
Clinical Trials running at Barrow Neurological Institute
Parkinson's Disease
Amyotrophic Lateral Sclerosis
Alzheimer's Disease
Scoliosis
Pompe Disease
Epilepsy
Myasthenia Gravis
Kyphosis
Down Syndrome
Dementia
CREXONT ER
for Parkinson's Disease
The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD).
Recruiting
3 awards
Phase 4
2 criteria
CVN424
for Parkinson's Disease
This is a randomized, double-blind, placebo-controlled, multicenter study in participants with Parkinson's disease (PD) with motor fluctuations. Participants will be randomized to receive once-daily oral doses of either 75 milligrams (mg) CVN424 or 150 mg CVN424, or a matching placebo for 12 weeks. Participants who successfully complete this study and retain eligibility/suitability will be invited to participate in a future open-label extension (OLE) study.
Recruiting
1 award
Phase 3
17 criteria
Genetic Registry
for Parkinson's Disease
Development of a central repository for PD-related genomic data for future research.
Recruiting
1 award
N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Barrow Neurological Institute?
Barrow Neurological Institute is a medical facility located in Phoenix, Arizona. This center is recognized for care of Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Parkinson's Disease, Epilepsy, Brain Tumor and other specialties. Barrow Neurological Institute is involved with conducting 160 clinical trials across 199 conditions. There are 16 research doctors associated with this hospital, such as Shafeeq S. Ladha, Anna Burke, Holly Shill, MD, and Margeaux E Snell, MD.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.